ICE Box organizes vital records, estate planning documents, and emergency files in one fireproof box with a 32GB USB stick and expert-developed checklist.
COPENHAGEN, Denmark, June 13, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced Week 182 data from its completed Phase 3 PaTHway Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) demonstrated sustained efficacy and safety in adults with hypoparathyroidism. Over the three-and-a-half-year duration of the trial, TransCon PTH replicated the systemic actions of endogenous PTH, with a balanced, beneficial impact on the main target organ systems – CNS, kidney, small intestine, and bone – as demonstrated by improved quality of life and normalized and stable urine calcium, serum calcium, serum phosphate, and bone mineral density. These benefits were sustained while enabling independence from conventional therapy with active vitamin D and calcium.
NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...
NEW YORK and ATHENS, Greece, June 13, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos"), a global life sciences investment firm bridging the US biopharma...
GOTHENBURG, Sweden, June 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation...
DUBLIN, Ireland, June 13, 2026 /CNW/ - Today, the Prime Minister, Mark Carney, met with the Taoiseach of Ireland, Micheál Martin, during his bilateral...
MANASSAS, Va., June 13, 2026 /PRNewswire/ -- PureHealth Research is spotlighting rising consumer interest in proactive thyroid wellness and the role of targeted nutritional...
MANASSAS, Va., June 13, 2026 /PRNewswire/ -- PureHealth Research today addressed the growing demand for proactive kidney wellness with its collection of science-backed renal...
FemiCore bladder control capsules 2026 — ingredient information, probiotic strain details, official website verification guidance, and the counterfeit-marketplace red flags consumers are encouraged to be aware of in the women's health supplement category.
FemiCore bladder control capsules 2026 — ingredient information, probiotic strain details, official website verification guidance, and the counterfeit-marketplace red flags consumers are encouraged to be aware of in the women's health supplement category.
Images HERESYDNEY, June 13, 2026 /PRNewswire/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...